Loading stock data…
MMSI
$67.52+0.01 (+0.01%)
Market OpenUpdated 1:31 PM EDT
Merit Medical Systems, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Merit Medical Systems, Inc. in the Healthcare sector is trading at $67.52 with a market capitalization of $3.8B. Wall Street consensus targets $89.55 (11 analysts), implying a +32.6% move over the next 12 months. The stock is currently 30% below its 52-week high of $96.74, remaining 13.8% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +32.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $381.88M↓ | $393.94M↑ | $384.16M↑ | $382.46M↑ | $355.35M |
| Gross Profit | $184.80M↓ | $195.35M↑ | $186.41M↑ | $184.49M↑ | $172.02M |
| Operating Income | $43.98M↓ | $53.98M↑ | $42.64M↓ | $47.02M↑ | $42.06M |
| Net Income | $40.99M↑ | $38.01M↑ | $27.75M↓ | $32.58M↑ | $30.15M |
Peer Comparison
JNJUNHPFE
Fundamentals
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and international...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.80B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
27.48
Beta
Defensive asset. Lower volatility than the S&P 500.
0.57
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.57%
Volume
Today's trading volume
393,378
Recent News
Is the Options Market Predicting a Spike in Merit Medical Systems Stock?
Investors need to pay close attention to MMSI stock based on the movements in the options market lately.
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
MMSI leans on therapeutic strength, an oncology acquisition and a new stent launch, but tariffs, OEM weakness and China pressure shadow 2026.
3 of Wall Street’s Favorite Stocks That Fall Short
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Is Merit Medical Systems (MMSI) Attractive After A 34% One Year Share Price Slide
Wondering whether Merit Medical Systems at around US$62 per share reflects a fair price, a discount, or a premium? This article breaks that question down into plain language so you can judge the stock's value for yourself. The stock has been under pressure, with the share price falling 3.3% over the past week and year-to-date returns down 28.2%, contributing to a 33.7% decline over the past year. These moves come as investors reassess medical equipment stocks generally, with sentiment...
Here's Why Merit Medical (MMSI) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.